Quick Answer
XBiotech Inc. reported Gross Profit of $0.00 for fiscal year 2023.
XBiotech Inc. Gross Profit — Annual History
| Fiscal Year | Gross Profit | YoY Change |
|---|---|---|
| 2023 | $0.00 | -100.0% |
| 2022 | $3.36M | -73.3% |
| 2021 | $12.57M | +33.1% |
| 2020 | $9.45M | — |
| 2019 | $0.00 | — |
| 2018 | $0.00 | — |
Quarterly Gross Profit
| Quarter Ending | Gross Profit | YoY | QoQ |
|---|---|---|---|
| September 30, 2023 | $0.00 | -100.0% | — |
| June 30, 2023 | $0.00 | -100.0% | — |
| March 31, 2023 | $0.00 | -100.0% | -100.0% |
| September 30, 2022 | $1.47M | -57.0% | +10.7% |
| June 30, 2022 | $1.32M | -58.2% | +361.0% |
| March 31, 2022 | $287.0K | -88.7% | -91.6% |
| September 30, 2021 | $3.41M | +203.6% | +7.7% |
| June 30, 2021 | $3.17M | +37.8% | +24.3% |
- XBiotech Inc. showed a decrease of -100.0% in Gross Profit compared to the prior fiscal year.
- The most recent figure is from XBiotech Inc.’s fiscal year 2023 report (Form 10-K), filed with the SEC on March 15, 2024.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: